This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Korea's FuriosaAI frames power, inference limits as next test for AI hardware

By Choonsik Yoo ( February 6, 2026, 05:58 GMT | Insight) -- South Korean AI chip startup FuriosaAI says mounting bottlenecks in inference hardware, electricity supply and data-center capacity are shifting attention away from AI training and toward deployment efficiency, as it moves to scale production of its inference-focused accelerators. At a recent meeting with journalists, the company argued that inference workloads place different technical and cost pressures on semiconductors than training, and said early enterprise use and international partnerships reflect growing interest in alternatives designed for large-scale inference.South Korean AI chip startup FuriosaAI, often described a credible challenger to industry titan Nvidia, says the intensifying global bottlenecks in inference hardware and power reinforce its decision to bet on high-end AI inference accelerators....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections